Medical Weight Loss for Mishawaka, Indiana Residents

Mishawaka, Indiana residents get physician-supervised weight loss by telehealth from New Hope Weight Loss: a $119 doctor review, then compounded semaglutide from $166/month or tirzepatide from $233/month.

Physician-supervised GLP-1 programs from $166/month, serving Mishawaka through telehealth from our Costa Mesa, California clinic. Doctor review $119. Over 5,400 patients treated.

Private and discreet across Indiana: there is no local Mishawaka office to walk into and no one to run into, your entire program runs through secure video and direct shipping. Doctor review just $119 (medication separate).

Why Mishawaka Residents Choose New Hope Weight Loss

You never have to leave Mishawaka to work with us. The entire program runs by telehealth from our clinic in Costa Mesa, California, so your consultation, your follow-ups, and your dose adjustments all happen by video and message from wherever you are in Indiana. Whether you live near downtown Mishawaka and the South Bend-Mishawaka area of St. Joseph County or further out, the care is identical. No commute, no waiting room, no rearranging your week around an appointment across town.

Mishawaka is part of the area New Hope Weight Loss serves by telehealth. The same compounded semaglutide and tirzepatide protocols, the same flat pricing, and the same bilingual support reach Mishawaka patients at home.

Living in Mishawaka, Indiana means your weight-loss care comes to you online rather than the other way around, with Dr. Anjmun Sharma supervising each step from our Costa Mesa practice. We care for patients throughout downtown Mishawaka and the South Bend-Mishawaka area of St. Joseph County. Every prescription is reviewed and authorized by Dr. Anjmun Sharma, MD, before anything is sent to your address in Indiana.

You can start this week from anywhere in Indiana, because telehealth removes the drive, the parking, and the weeks of waiting that a local clinic would require. If you would rather spread payments out, Mishawaka patients can use Klarna or Affirm at checkout instead of paying the full cost at once. New Hope Weight Loss treats patients throughout Indiana entirely by telehealth from our Costa Mesa, California clinic, so the same physician care comes to you wherever you live in the state.

GLP-1 Weight Loss Programs Available

Begin your reset: semaglutide, from $166/mo

The 90-Day Metabolic Reset gives Mishawaka patients a structured three-month plan with semaglutide, the active ingredient shared with Wegovy and Ozempic. Choose $166 a month or $499 for the whole 90 days. In trials of the branded drug, the average was around 15 to 17 percent body-weight loss. Compounded semaglutide is not FDA-approved and not brand-identical, and results vary.

Go further: tirzepatide, from $233/mo

Tirzepatide hits both GLP-1 and GIP receptors for a dual effect. Qualifying doses in branded-drug trials reached up to 22.5 percent loss, which is not what most patients should expect. It carries the same active ingredient as Mounjaro and Zepbound.

Each plan begins with a $119 physician review. Medication is billed separately. HSA, FSA, Klarna, and Affirm accepted.

How Telehealth Works for Mishawaka

Step 1. Complete the online intake and weight-history quiz from your phone or laptop.

Step 2. Dr. Sharma reviews everything and meets you over secure video, typically within 48 hours, to confirm whether compounded semaglutide or tirzepatide makes sense for you.

Step 3. If appropriate, a state-licensed 503(a) pharmacy ships your medication to your Mishawaka home in insulated cold-pack packaging.

Step 4. You check in by video for follow-ups, so adjusting your dose never means a drive across .

Frequently Asked Questions, Mishawaka

I am searching for weight loss care near Mishawaka. Where are you?

We are based in Costa Mesa, California, where our only physical clinic operates. Patients in Mishawaka, Indiana connect with us by telehealth instead of visiting. Dr. Anjmun Sharma conducts a video consult to review your goals and confirm whether you qualify for a compounded GLP-1 medication program.

Do I need to be seen in person if I live in Mishawaka?

Not at all. The telehealth format covers Mishawaka patients from start to finish, so no clinic visit is ever required. You speak with Dr. Sharma by video, and once you are approved, compounded medication ships to Mishawaka in cold-pack packaging built to keep it cool and stable.

What are the program costs for Mishawaka patients?

The physician review is priced at $119. Compounded semaglutide is available from $166 a month or $499 for the 90-day plan, and tirzepatide from $233 a month. Medication is invoiced separately. Payment options include HSA, FSA, Klarna, and Affirm, and Mishawaka patients face no distance surcharge.

What areas of Mishawaka do you serve?

We serve patients from across Mishawaka by telehealth, including downtown Mishawaka and the South Bend-Mishawaka area of St. Joseph County.

How does compounded medication compare on cost for Mishawaka patients?

Compounded semaglutide from $166/month and tirzepatide from $233/month are a fraction of typical brand-name cash prices. Mishawaka patients see flat pricing up front, and compounded semaglutide and tirzepatide are not FDA-approved or brand-identical, which Dr. Sharma reviews with you.

Mishawaka Residents, Get Started Today

Doctor review $119. Semaglutide from $166/mo. Tirzepatide from $233/mo. Medication separate.

Start My Journey →

New Hope Weight Loss | clinic at 1503 South Coast Drive, Suite 322, Costa Mesa, CA 92626 | (657) 837-3342 | Serving Mishawaka, Indiana by telehealth. Telehealth availability and eligibility are confirmed during the medical consultation.

Wegovy® and Ozempic® are registered trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company. New Hope Weight Loss is not affiliated with or endorsed by these companies. Compounded semaglutide and tirzepatide are prepared by licensed U.S. pharmacies and are not FDA-approved, not brand-identical, and not reviewed by the FDA for safety, effectiveness, or quality.